Column Group Management LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 4,382 shares at $13.98 ($61K) on 2019-08-01, disclosed to the SEC on 2019-08-05.
Open-market purchase of $61k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.98 | 2,600 | $36K | 59.4% |
| 2 | $13.97 | 1,782 | $25K | 40.6% |
| Total | $13.98 avg | 4,382 | $61K | 100% |
| Filing → |
| NGM | BUY | 2020-04-07 | $3.9M | — | Filing → |
| NGM | BUY | 2019-11-06 | $202K | — | Filing → |
| NGM | BUY | 2019-04-10 | $30.2M | — | Filing → |